Showing 961-970 of 3538 results for "".
A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.The Gold Rush: What’s the Value?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-gold-rush-whats-the-value/23537/Trend Alert: Gold is popping up in many skincare lines, but will it live up to the hype?COVID-19 and a Transition to Teledermatology
https://practicaldermatology.com/topics/practice-management/covid-19-and-a-transition-to-teledermatology/23353/Teledermatology may play a role as a triage and monitoring tool to help reduce unnecessary referrals and long wait times.Building Dermatology Patient Relationships with AI Chat and Text Messaging
https://practicaldermatology.com/topics/practice-management/building-dermatology-patient-relationships-with-ai-chat-and-text-messaging/23188/Automated communication tools could actually be the secret to a personal touch.Understanding the Role of Natural Moisturizing Factor in Skin Hydration
https://practicaldermatology.com/topics/general-topics/understanding-the-role-of-natural-moisturizing-factor-in-skin-hydration/21612/Components collectively called natural moisturizing factor (NMF) that occur naturally in the skin can be delivered topically to treat xerotic, dry skin.New Advancements in Microneedle Resurfacing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-advancements-in-microneedle-resurfacing/21354/Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.New FDA Approval for AD
https://practicaldermatology.com/series/c-suite-chats/new-fda-approval-for-ad/29911/Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, talks about the importance of a new FDA-approved topical solution for treating atopic dermatitis.DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecTreatment Considerations in the Short- and Long-Term Management of Plaque Psoriasis: Is There A Role for Tazarotene?
https://practicaldermatology.com/topics/psoriasis/treatment-considerations-in-the-shortandlong-term-management-of-plaquepsoriasis-is-there-a-role-for-tazarotene/23041/Tazarotene is almost a forgotten entity in management of psoriasis, despite quality data showing it can be both tolerable and effective—when used appropriately.Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.